BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 22922447)

  • 1. Analysis of the absence of the detrusor muscle in initial transurethral resected specimens and the presence of residual tumor tissue.
    Huang J; Fu J; Zhan H; Xie K; Liu B; Yang F; Lu Y; Zhou X
    Urol Int; 2012; 89(3):319-25. PubMed ID: 22922447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The presence of detrusor muscle in the pathological specimen after transurethral resection of primary pT1 bladder tumors and its relationship to operator experience.
    Rouprêt M; Yates DR; Varinot J; Phé V; Chartier-Kastler E; Bitker MO; Compérat E
    Can J Urol; 2012 Oct; 19(5):6459-64. PubMed ID: 23040628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking.
    Mariappan P; Finney SM; Head E; Somani BK; Zachou A; Smith G; Mishriki SF; N'Dow J; Grigor KM;
    BJU Int; 2012 Jun; 109(11):1666-73. PubMed ID: 22044434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of detrusor muscle in bladder tumor specimens--predictors and effect on outcome as a measure of resection quality.
    Shoshany O; Mano R; Margel D; Baniel J; Yossepowitch O
    Urol Oncol; 2014 Jan; 32(1):40.e17-22. PubMed ID: 23911682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Repeat transurethral resection for non-muscle invasive bladder cancer].
    Shen YJ; Ye DW; Yao XD; Zhang SL; Dai B; Zhu YP; Zhang HL; Zhu Y; Shi GH; Ma CG
    Zhonghua Wai Ke Za Zhi; 2009 May; 47(10):725-7. PubMed ID: 19615201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Complete transurethral resection of bladder tumor": are the guidelines being followed?
    Adiyat KT; Katkoori D; Soloway CT; De los Santos R; Manoharan M; Soloway MS
    Urology; 2010 Feb; 75(2):365-7. PubMed ID: 19963238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detrusor Muscle in TUR-Derived Bladder Tumor Specimens: Can We Actually Improve the Surgical Quality?
    Capogrosso P; Capitanio U; Ventimiglia E; Boeri L; Briganti A; Colombo R; Montorsi F; Salonia A
    J Endourol; 2016 Apr; 30(4):400-5. PubMed ID: 26597334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of a second transurethral resection in evaluating patients with bladder tumors.
    Herr HW
    J Urol; 1999 Jul; 162(1):74-6. PubMed ID: 10379743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
    Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the risk of high-grade bladder cancer using noninvasive data.
    Shapur N; Pode D; Katz R; Shapiro A; Yutkin V; Pizov G; Appelbaum L; Zorn KC; Duvdevani M; Landau EH; Gofrit ON
    Urol Int; 2011; 87(3):319-24. PubMed ID: 21849760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?
    Herr HW; Donat SM; Dalbagni G
    J Urol; 2007 Jan; 177(1):75-9; discussion 79. PubMed ID: 17162005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
    Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
    J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of tumor-free status in repeat resection before intravesical bacillus Calmette-Guerin for high grade Ta, T1 and CIS bladder cancer.
    Guevara A; Salomon L; Allory Y; Ploussard G; de la Taille A; Paul A; Yiou R; Hoznek A; Dahan M; Abbou CC; Vordos D
    J Urol; 2010 Jun; 183(6):2161-4. PubMed ID: 20399454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The quality of 5-aminolevulinic acid-induced photodynamic diagnosis and transurethral resection of bladder tumors: does the urologist play a role?
    Draga RO; Grimbergen MC; Kok ET; Jonges TN; van Swol CF; Bosch RJ
    Urol Int; 2012; 89(3):326-31. PubMed ID: 22986952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy.
    Kriegmair M; Zaak D; Rothenberger KH; Rassweiler J; Jocham D; Eisenberger F; Tauber R; Stenzl A; Hofstetter A
    J Urol; 2002 Aug; 168(2):475-8. PubMed ID: 12131291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residual pathological stage at radical cystectomy significantly impacts outcomes for initial T2N0 bladder cancer.
    Isbarn H; Karakiewicz PI; Shariat SF; Capitanio U; Palapattu GS; Sagalowsky AI; Lotan Y; Schoenberg MP; Amiel GE; Lerner SP; Sonpavde G
    J Urol; 2009 Aug; 182(2):459-65; discussion 465. PubMed ID: 19524971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The actual incidence of bladder perforation following transurethral bladder surgery.
    Balbay MD; Cimentepe E; Unsal A; Bayrak O; Koç A; Akbulut Z
    J Urol; 2005 Dec; 174(6):2260-2, discussion 2262-3. PubMed ID: 16280794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory pseudotumor and sarcoma of urinary bladder: differential diagnosis and outcome in thirty-eight spindle cell neoplasms.
    Iczkowski KA; Shanks JH; Gadaleanu V; Cheng L; Jones EC; Neumann R; Nascimento AG; Bostwick DG
    Mod Pathol; 2001 Oct; 14(10):1043-51. PubMed ID: 11598176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual tumour in the marginal resection after a complete transurethral resection is associated with local recurrence in Ta/T1 urinary bladder cancer.
    Jancke G; Rosell J; Jahnson S
    Scand J Urol Nephrol; 2012 Oct; 46(5):343-7. PubMed ID: 22564077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy.
    Herr HW
    J Urol; 2005 Dec; 174(6):2134-7. PubMed ID: 16280743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.